Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
[18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects
FranceIndocyanine Green and Near-Infrared Fluorescence for Lymph Node Removal in Children with Renal Tumours or Paratesticular Rhabdomyosarcoma
The NetherlandsA study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.
BelgiumA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
BelgiumA study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome
CzechiaA study to evaluate the safety of MRM-3379 in men with Fragile X Syndrome
SpainA study using [11C]ORM-13070 to examine the effects of aging and Parkinson's disease on specific brain receptors.
FranceA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
BelgiumA Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome
BelgiumA study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis
BelgiumA study to evaluate the use of levothyroxine sodium in patients with sudden onset of dizziness caused by inner ear issues.
GermanyA study to evaluate the safety of VTx-002 in patients with amyotrophic lateral sclerosis.
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
